✦ LIBER ✦
864 Intravenous (IV) vinorelbine (VRL) plus hormone therapy (HT) versus hormone therapy alone in hormone-refractory prostate cancer (HRPC). Final report of a randomised phase III study
✍ Scribed by R.P. Abratt; D. Brune; M.A. Dimopoulos; J. Kliment; J. Breza; P. Selvaggi; P. Beuzeboc; T. Demkow; S. Oudard
- Book ID
- 118621030
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 167 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.